Blog
RSS FeedPosted by Michael Wonder on 20 May 2019
Health Technology Assessment Consumer Consultative Committee March 2019 meeting communiqué
20 May 2019 - A communiqué from the March 2019 meeting of the HTA Consumer Consultative Committee has been published. ...
Posted by Michael Wonder on 28 Mar 2019
Keeping up the PACE at the Scottish Medicines Consortium
26 March 2019 - There are many ways that patient centricity could be delivered when doing a health technology assessment. ...
Posted by Michael Wonder on 17 Mar 2019
Toward a strategy to involve patients in health technology assessment in Spain
14 March 2019 - The aim of this study was to develop a feasible and effective strategy to involve patients in ...
Posted by Michael Wonder on 06 Mar 2019
Patient advocacy groups in Canada with ties to pharma are big boosters for government coverage
5 March 2019 - As the interplay between the pharmaceutical industry and patient advocacy groups undergoes stepped-up scrutiny, a new ...
Posted by Michael Wonder on 27 Feb 2019
Patient experience data and bias — what ratings don’t tell us
28 February 2018 - Although patient-experience data are important to U.S. health care organisations, the best way to interpret them remains ...
Posted by Michael Wonder on 26 Feb 2019
The FDA's Oncology Center of Excellence — quantifying the patient experience
23 February 2019 - Cancer therapies are typically evaluated based on their ability to control the growth of a tumor ...
Posted by Michael Wonder on 20 Feb 2019
Updates for patients and communities
20 February 2019 - After spending the fall listening to patient groups and exploring how other organisations have involved patients ...
Posted by Michael Wonder on 19 Feb 2019
My Health Record reflects 'new consensus', says CEO Tim Kelsey
19 February 2019 - The government's controversial My Health Record was part of a "new consensus" on digital health, said ...
Posted by Michael Wonder on 14 Feb 2019
NICE provides first scientific advice on patient preference study design
14 February 2019 - The NICE Scientific Advice team, working with the Science Policy and Research team at NICE, has provided ...
Posted by Michael Wonder on 28 Jan 2019
Cystic fibrosis patients lobby Vertex to drop drug prices
28 January 2019 - Healthcare professionals and patient groups have written to Vertex’s CEO Jeffrey Leiden in a bid to ...
Posted by Michael Wonder on 25 Jan 2019
My Health Record enshrines choice
24 January 2019 - A change in the law enabling people to delete permanently their My Health Record, should strengthen ...
Posted by Michael Wonder on 23 Jan 2019
Citizens ask - scientists answer: the IQWiG sets four new topics for HTA reports
23 January 2019 - Citizens, patients and medical experts: selection of topics with a sense of proportion ...
Posted by Michael Wonder on 20 Jan 2019
Tauranga women fighting cancer, and fighting the system
19 January 2019 - Two Tauranga woman, each living with a terminal diagnosis, are calling for an independent inquiry into ...
Posted by Michael Wonder on 18 Jan 2019
Patient groups fail to declare financial interests during NICE assessments
16 January 2019 - Patients’ groups involved in assessing treatments for the NHS often fail to disclose their financial interests, ...
Posted by Michael Wonder on 16 Jan 2019
Pharmaceutical companies spent $34m on patient advocacy groups, research finds
16 January 2019 - Money often spent while companies had drugs ‘under review for public reimbursement’ through PBS. ...